Pharmaceutical Field - Non-Exec Directors join GSK board

Non-Exec Directors join GSK board

GSK has appointed Lynn Elsenhans and Jing Ulrich as Non-Executive Directors to its Board.

The two will join the company from 1July 2012 after being recommended by GSK’s Nominations Committee.

Sir Christopher Gent, GSK Chairman, said the appointments will help take “GSK’s global business forward”.

The former Chair, President and CEO of Sunoco Inc, a leading transportation fuel provider in the US, from 2009 to 2012, Lynn Elsenhans previously served at Royal Dutch Shell for nearly 30 years.

Ms Jing Ulrich, currently the Managing Director and Chairman of Global Markets, China at J.P. Morgan, serves as an advisor to global organisations across various industries and asset classes. She also advises Chinese institutions making investments overseas.

“I am delighted to welcome Lynn and Jing to the Board of GSK,” said Sir Christopher.

He added the appointments reflect GSK’s “priority of appointing candidates who have deep knowledge of Emerging Markets or experience of running global companies.”

GSK has also made two additions to its Remuneration Committee and two to its Nominations Committee. Sir Deryck Maughan will join the Remuneration Committee from 1 July 2012 and be joined by Judy Lewent from 1 January 2013. Tom de Swaan and Professor Roy Anderson will join the Nominations Committee from next year onwards.